Editor-in-Chief, MedTech Strategist & Market Pathways
Editor-in-Chief, MedTech Strategist & Market Pathways
Managing Partner, Innovation In Medtech, LLC
Website: MyStrategist.com
Stephen Levin has spent more than 25 years covering the life sciences industry, writing and speaking primarily on medical technology worldwide. He and his long-time colleague, David Cassak, have launched, Innovation In Medtech, LLC, in 2014 which features a pair of medtech publications, MEDTECH STRATEGIST and MARKET PATHWAYS, along with industry-leading investor conferences in Dublin, Ireland, and San Francisco.
Levin formerly was Editor-in-Chief/Medical Devices at Elsevier Business Intelligence (EBI), from 2008 until EBI was acquired by Informa in 2013. At EBI, he directed the editorial coverage for the company’s medtech publications, including IN VIVO, START-UP, MEDTECH INSIGHT, THE GRAY SHEET, and THE SILVER SHEET, along with the content for the Investment In Innovation (IN3) series of medical device partnering conferences. EBI was formed in 2008 when Elsevier acquired Windhover Information and combined Windhover with FDC Reports. He had joined Windhover in 1997, where as Executive Editor, he supervised the editorial operations of IN VIVO, START-UP, and MEDTECH INSIGHT, while also covering the device industry, distribution, and legal issues. He also served as the company’s General Counsel.
Prior to his medtech career, Levin was Senior Counsel to the US Senate Permanent Subcommittee on Investigations, where he directed Senate investigations into a wide variety of areas including health care fraud and abuse, international organized crime, and corruption in federal contracting programs, while also participating in other Senate investigations, including the Whitewater inquiry. Before joining the Subcommittee, Levin was an enforcement and regulatory attorney in the Federal Election Commission’s Office of General Counsel, and also worked at the US Department of Justice. He was formerly an Editor of HEALTH INDUSTRY TODAY, a leading publication in the health care distribution industry.